Terms: = Ovarian cancer AND GRIN2A, Q12879, 2903, ENSG00000183454, NMDAR2A, NR2A
6 results:
1. Molecular targets of metformin against ovarian cancer based on network pharmacology.
Guo JY; Wang YJ; Li SQ; Wu YP
Chem Biol Drug Des; 2023 Jul; 102(1):88-100. PubMed ID: 36977503
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic Markers and Statistical Prediction of Serous ovarian cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging.
Sans M; Gharpure K; Tibshirani R; Zhang J; Liang L; Liu J; Young JH; Dood RL; Sood AK; Eberlin LS
Cancer Res; 2017 Jun; 77(11):2903-2913. PubMed ID: 28416487
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
Li J; Wang J; Chen R; Bai Y; Lu X
Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
[TBL] [Abstract] [Full Text] [Related]
4. VAV3 Overexpressed in cancer Stem Cells Is a Poor Prognostic Indicator in ovarian cancer Patients.
Kwon AY; Kim GI; Jeong JY; Song JY; Kwack KB; Lee C; Kang HY; Kim TH; Heo JH; An HJ
Stem Cells Dev; 2015 Jul; 24(13):1521-35. PubMed ID: 25715123
[TBL] [Abstract] [Full Text] [Related]
5. [Identification of NMDA receptor in normal bovine ovary and ovum].
Tachibana N; Ikeda S
Rinsho Shinkeigaku; 2014; 54(12):1031-3. PubMed ID: 25672700
[TBL] [Abstract] [Full Text] [Related]
6. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.
Dalmau J; Tüzün E; Wu HY; Masjuan J; Rossi JE; Voloschin A; Baehring JM; Shimazaki H; Koide R; King D; Mason W; Sansing LH; Dichter MA; Rosenfeld MR; Lynch DR
Ann Neurol; 2007 Jan; 61(1):25-36. PubMed ID: 17262855
[TBL] [Abstract] [Full Text] [Related]
